Only on the advice of a Medical Microbiologist or Infection Specialist for the following
indication where alternative options have been considered:
1. Treatment of adults with confirmed carbapenem-resistant Enterbacteriaceae
(CRE), which is involved in the production of Klebsiella pneumoniae
carbapenemase (KPC) associated with complicated urinary tract infection
(including acute pyelonephritis), complicated intra-abdominal infection,
hospital acquired pneumonia (including ventilator associated pneumonia) and
bacteraemia that occurs in association with, or is suspected to be associated
with any of the infections previously mentioned.
Not licensed for use in children.
Only 24 hour supply of meropenem/vaborbactam stocked at ARI - please contact your ward pharmacist as soon as possible if this is required.